Qingbang Xu

605 total citations
8 papers, 396 citations indexed

About

Qingbang Xu is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, Qingbang Xu has authored 8 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Anesthesiology and Pain Medicine. Recurrent topics in Qingbang Xu's work include Pain Mechanisms and Treatments (4 papers), Shoulder Injury and Treatment (1 paper) and COVID-19 and Mental Health (1 paper). Qingbang Xu is often cited by papers focused on Pain Mechanisms and Treatments (4 papers), Shoulder Injury and Treatment (1 paper) and COVID-19 and Mental Health (1 paper). Qingbang Xu collaborates with scholars based in China and United States. Qingbang Xu's co-authors include Yang Yang, Xiaoliu Liu, Jie Wang, Zitong Gao, Youping Deng, Ling Hu, Shaoqiu Chen, Yi Zuo, Junjie Hao and Jia Liu and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Genetics and BMC Musculoskeletal Disorders.

In The Last Decade

Qingbang Xu

7 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingbang Xu China 5 259 138 99 44 39 8 396
Makhyan Jibril Al Farabi Indonesia 9 176 0.7× 113 0.8× 54 0.5× 23 0.5× 24 0.6× 36 348
Jinguo Chu China 8 308 1.2× 126 0.9× 79 0.8× 43 1.0× 23 0.6× 17 547
Dan Jiang China 9 195 0.8× 116 0.8× 48 0.5× 20 0.5× 22 0.6× 23 382
Haitao Tu China 9 111 0.4× 57 0.4× 55 0.6× 27 0.6× 36 0.9× 19 420
Qinqin Yan China 7 239 0.9× 118 0.9× 44 0.4× 37 0.8× 13 0.3× 15 384
Yanbin Du China 5 117 0.5× 66 0.5× 52 0.5× 20 0.5× 32 0.8× 9 244
Donogh Maguire United Kingdom 12 81 0.3× 92 0.7× 36 0.4× 35 0.8× 10 0.3× 25 426
Ciro Canetta Italy 9 83 0.3× 75 0.5× 46 0.5× 63 1.4× 27 0.7× 33 410
Xiuqin Hong China 10 95 0.4× 41 0.3× 45 0.5× 33 0.8× 24 0.6× 29 363
Juan Simón Rico-Mesa United States 4 175 0.7× 86 0.6× 40 0.4× 42 1.0× 16 0.4× 9 307

Countries citing papers authored by Qingbang Xu

Since Specialization
Citations

This map shows the geographic impact of Qingbang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbang Xu more than expected).

Fields of papers citing papers by Qingbang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingbang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbang Xu. The network helps show where Qingbang Xu may publish in the future.

Co-authorship network of co-authors of Qingbang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingbang Xu. A scholar is included among the top collaborators of Qingbang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingbang Xu. Qingbang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Xu, Qingbang, Xiaolan Zheng, Ling Hu, & Jing Zheng. (2024). Impact of transdermal buprenorphine patch combined with celecoxib on improving shoulder pain and function of patients with primary adhesive shoulder capsulitis. BMC Musculoskeletal Disorders. 25(1). 953–953.
2.
Ni, Wan, et al.. (2023). Spinal Cord Stimulation Alleviates Pain Hypersensitivity by Attenuating Neuroinflammation in a Model of Painful Diabetic Neuropathy. Journal of Integrative Neuroscience. 22(3). 67–67. 6 indexed citations
3.
Hu, Ling, et al.. (2023). Gene expression signature of human neuropathic pain identified through transcriptome analysis. Frontiers in Genetics. 14. 1127167–1127167. 4 indexed citations
4.
Xu, Qingbang, Xianliang Hu, Yan Yang, et al.. (2022). Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker. Frontiers in Genetics. 13. 944970–944970. 8 indexed citations
5.
Hu, Ling, Shaoqiu Chen, Yuanyuan Fu, et al.. (2020). Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China. Clinical Infectious Diseases. 71(16). 2089–2098. 296 indexed citations
6.
Ni, Wan, et al.. (2020). Antinociceptive Effects of Emodin on CFA-Induced Inflammatory Pain in Rats. Natural Product Communications. 15(7). 3 indexed citations
7.
Ni, Wan, Xiaolan Zheng, Ling Hu, Chao Kong, & Qingbang Xu. (2020). Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats. Experimental and Therapeutic Medicine. 21(2). 135–135. 10 indexed citations
8.
Yang, Yang, et al.. (2018). Emodin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Anti-Inflammatory and Anti-Oxidative Activities in Rats. Medical Science Monitor. 24. 1–10. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026